chevron_leftBack
As of 24 April 2025, Sartorius Stedim Biotech S.A. has a market cap of $22.29B USD, ranking #865 globally and #30 in France. It ranks #74 in the Healthcare sector, and #9 in the Medical Instruments & Supplies industry.
Key Stats
Market Cap
$22.29BUSD
19.59B EUR
Enterprise Value
$24.86BUSD
21.85B EUR
Revenue (TTM)
$3.25BUSD
2.86B EUR
EBITDA (TTM)
$759.58MUSD
667.5M EUR
Net Income (TTM)
$232.48MUSD
204.3M EUR
EBITDA Margin
23%
Profit Margin
7.1%
PE Ratio
95.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Instruments & Supplies
CEO
Rene Faber
open_in_new
Employees
9,901
Founded
1978
Website
sartorius.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.1% | 6.3% | 2.1% | -3.8% | 1.5% | -4.7% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
DIM
Sartorius Stedim Biotech SA
ISIN: FR0013154002
Shares Out.:
Shares Outstanding:
97.3M1
Shares Float:
25.651M2
|
201.10 EUR | |
|
0RG8
Sartorius Stedim Biotech SA
ISIN: FR0013154002
|
162.46 EUR | |
|
56S1
Sartorius Stedim Biotech SA
ISIN: FR0013154002
|
191.05 EUR | |
|
56S1
Sartorius Stedim Biotech SA
ISIN: FR0013154002
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
194.10 EUR | |
|
DIM-N
(DIM/N)
Sartorius Stedim Biotech SA
ISIN: FR0013154002
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
4.24K MXN | |
|
SDMHF
Sartorius Stedim Biotech SA
ISIN: FR0013154002
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
218.00 USD | |
|
SRTOY
Sartorius Stedim Biotech SA ADR
ISIN: US80386Y1010
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
23.13 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Sartorius Stedim Biotech S.A.
Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiology testing, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; screening instruments; biomolecule analysis tools; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; water purification systems; and weighing products. In addition, the company offers data analytics software; process automation platform and software; and transfection reagents and plasmid DNA solutions. It serves manufacturers of medications, vaccines, food, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. Sartorius Stedim Biotech S.A. is a subsidiary of Sartorius AG.
